Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04683627 · ClinicalTrials.gov registry record · Phase 3
A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee
A Phase 3 study of Osteoarthritis Pain of the Knee, sponsored by Noven Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 370
- Enrollment target
- 10
- Study locations
NCT04683627: Completed Phase 3 study of Osteoarthritis Pain of the Knee, sponsored by Noven Pharmaceuticals.
NCT04683627 is a Phase 3 study of Osteoarthritis Pain of the Knee that has completed, run by Noven Pharmaceuticals. The registered enrollment target is 370 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (52% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04683627, a Phase 3 study of Osteoarthritis Pain of the Knee, has completed, sponsored by Noven Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 370 participants
- Enrollment target
- 10
- Study locations
Study Summary
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee
Conditions Studied
Interventions
- DRUG Placebo patch
- DRUG Diclofenac sodium active topical patch
Study Locations (10)
Florida
- Clinical Research of West Florida,Inc. - Clearwater
- Universal Axon Clinical Research, LLC - Doral
Texas
- Metroplex Clinical Research Center - Dallas
- Quality Research Inc. - San Antonio
Arkansas
- Applied Research Center of Arkansas - Little Rock
Louisiana
- The Arthritis and Diabetes Clinic, Inc. - Monroe
New Jersey
- Noven Pharmaceuticals, Inc. - Jersey City
Ohio
- Velocity Clinical Research - Cincinnati
Rhode Island
- Partners in Clinical Research - Cumberland
South Carolina
- Palmetto Clinical Research - Summerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2022-07-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04683627
The ClinicalTrials.gov registry entry for NCT04683627 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (52% lower). The listed sponsor is Noven Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis Pain of the Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo patch is the first listed.
NCT04683627 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Texas, Arkansas.
Frequently Asked Questions
What is clinical trial NCT04683627 about?
NCT04683627 is a clinical study titled "A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee". A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee
What is the current status of trial NCT04683627?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 370 participants. The study started on 2020-12-29. Estimated completion is 2022-07-25.
What conditions does trial NCT04683627 study?
This clinical trial studies the following conditions: Osteoarthritis Pain of the Knee.
What interventions are being tested in trial NCT04683627?
The interventions under investigation include: Placebo patch (DRUG), Diclofenac sodium active topical patch (DRUG).
Who is sponsoring clinical trial NCT04683627?
This trial is sponsored by Noven Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04683627 being conducted?
This trial has 10 study locations across Arkansas, Florida, Louisiana, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.